MorphoSys Fills Out Pipeline With Xencor Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
After searching a year and a half for the right compound to complete its proprietary pipeline, German MorphoSys completed a biotech-biotech deal with a simpatico California company.